Associate Medical Director / Medical Director, Clinical Development
TempusFull Time
Junior (1 to 2 years)
Candidates should possess a board-certified clinical laboratory molecular geneticist with experience in hereditary disease screening and diagnostic genetic testing, demonstrating a solid understanding of molecular and cytogenetic methods used for hereditary disease genetic screening and diagnostics, including for reproductive carrier screening, non-invasive prenatal screening, prenatal diagnostic genetic testing, congenital genetic disorders, neurological genetic disorders, hereditary cancer, cardiovascular disorders, metabolic disorders, rare disease, and pharmacogenetics. Strong experience operating at the intersection of medical and commercial activities, coupled with a history of successful impact at clinical genomics laboratories utilizing next-generation sequencing technologies for hereditary disease, is required, along with a broad network of connections with key opinion leaders and a strong record of research and publications in hereditary disease.
This role will execute the medical affairs strategy in the United States in close coordination with the company’s strategic goals, representing Medical Affairs within cross-functional teams focused on hereditary disease and reproductive genetics, working closely with Commercial, Business Development, Pharma, R&D, Product Marketing, Regulatory, Bioinformatics, Assay Development, and Quality teams. The Associate Director will monitor and interpret changes in employment legislation across North America and develop HR policies to ensure compliance. They will conduct audits, deliver training, and advise management on HR-related risk mitigation strategies, as well as actively participate in the product development process in R&D to guide specifications for Illumina’s RUO and IVD products, support the execution of the product launch strategy, and ensure internal and external launch readiness, and execute US medical affairs strategies for evidence generation and scientific communication for hereditary disease diagnostic genetic testing, reproductive genetic screening, newborn sequencing, and broad population screening.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.